Gerretys LLC is categorized under Pharmaceutical Manufacturing Plant Construction in Seaforth, MN and active since 2005.
Gerretys LLC was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Manufacturing Plant Construction business, which does work in the B2B market, and is classified as a Pharmaceutical Manufacturing Plant Construction, under code number 236220 by the NAICS.
If you are seeking more information, feel free to contact Michael Gerrety at the company’s single location by writing to 23175 295th St, Seaforth, Minnesota MN 56287 or by phoning (507) 984-5405. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Gerretys LLC |
| Contact Person: | Michael Gerrety |
| Address: | 23175 295th St, Seaforth, Minnesota 56287 |
| Phone Number: | (507) 984-5405 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Pharmaceutical Manufacturing Plant Construction |
| SIC Code: | 1541 |
| NAICS Code: | 236220 |
| Share This Business: |
Gerretys LLC was started in 2005 to provide professional Pharmaceutical Manufacturing Plant Construction under the SIC code 1541 and NAICS code 236220. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael Gerrety for inquiries that concern Gerretys LLC by calling the company number (507) 984-5405, as your correspondence is most welcome. Additionally, the physical location of the single location of Gerretys LLC can be found at the coordinates 44.480025,-95.329129 as well as the street address 23175 295th St in Seaforth, Minnesota 56287.
For its online presence, you may visit Gerretys LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.